Stock comparison
Eli Lilly
Sotera Health
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LLY
Eli Lilly
Market cap
$946.37B
Sector
Healthcare
SHC
Sotera Health
Market cap
$4.35B
Sector
Healthcare
Overall winner
Eli Lilly LLY
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LLY | SHC | Winner |
|---|---|---|---|
| Warren Buffett | 65B | 51C | LLY |
| Benjamin Graham | 76B | 78B | SHC |
| Philip Fisher | 75B | 47D | LLY |
| Peter Lynch | 64C | 30F | LLY |
| Joel Greenblatt | 68B | 24F | LLY |
| Charlie Munger | 75B | 54C | LLY |
| Terry Smith | 66B | 52C | LLY |
Side-by-side metrics
| Metric | LLY | SHC |
|---|---|---|
| Market cap | $946.37B | $4.35B |
| P/E (TTM) | 35.6x | 36.9x |
| EV/EBIT | 33.2x | 16.1x |
| ROIC (TTM) | 32.06% | 7.96% |
| Gross margin | 83.51% | 55.01% |
| Net margin | 34.98% | 9.91% |
| Revenue CAGR 5y | 23.17% | 5.72% |
| EPS CAGR 5y | 40.81% | -9.92% |
| Debt / Equity | 1.4x | 3.6x |
| Dividend yield | 0.64% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LLY leads on
- EPS CAGR 5y40.81%vs -9.92%+124%
- Dividend yield0.64%vs 0.0%+100%
- Market cap$946.37Bvs $4.35B+100%
- Revenue CAGR 5y23.17%vs 5.72%+75%
SHC leads on
- EV/EBIT16.1xvs 33.2x+52%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.